Novo Holdings A/S’s Boston Scientific BSX Stock Holding History

Novo Holdings A/S’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,353,081	Closed	-$62.6M	–	48
2022 Q4	$62.6M	Sell	1,353,081 -409,861	-23%	-$17.7M	3.91%	9
2022 Q3	$68.3M	Sell	1,762,942 -1,745,846	-50%	-$70M	3.26%	9
2022 Q2	$131M	Buy	3,508,788 +45,211	+1%	+$1.84M	6.44%	4
2022 Q1	$153M	Hold	3,463,577	–	–	8.09%	3
2021 Q4	$147M	Hold	3,463,577	–	–	6.97%	5
2021 Q3	$150M	Buy	+3,463,577	New	+$153M	7.77%	3

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Novo Holdings A/S's BSX Position: Q1 2023 in Review

Novo Holdings A/S sold out of Boston Scientific (BSX) in Q1 2023, closing a stake of 1,353,081 shares — an estimated $62.6M sold.

Novo Holdings A/S first reported a position in BSX in Q3 2021 and held it in 6 quarters. The position peaked at $153M in Q1 2022. 996 funds tracked by Wall St. Rank hold BSX as of Q1 2023.

Novo Holdings A/S reported no remaining Boston Scientific position as of Q1 2023 after selling out during the quarter.
Novo Holdings A/S sold 1,353,081 Boston Scientific shares in Q1 2023, an estimated $62.6M.
Novo Holdings A/S first reported a position in Boston Scientific in Q3 2021 and held it in 6 quarters.
Novo Holdings A/S's Boston Scientific position peaked at $153M in Q1 2022.
996 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2023.

Based on Novo Holdings A/S's 13F filing for Q1 2023, filed 15 May 2023.